|Bid||29.190 x 48300|
|Ask||29.200 x 51100|
|Day's Range||29.170 - 29.800|
|52 Week Range||21.590 - 31.520|
|PE Ratio (TTM)||81.10|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VENLO, Netherlands, July 13, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2017 ...
Gold standard test for latent tuberculosis infection will be covered by national health insurance HILDEN , Germany , and PARIS , June 22, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime ...
GERMANTOWN, Md. and HILDEN, Germany, June 8, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON ® -TB Gold Plus ...